Aims and Scope
Expert Opinion on Drug Safety is a monthly peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre (University of Toronto).
Key Metrics
6.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
81
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.85 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Pharmacology (medical)
SJR
- Q2 Pharmacology (medical)
- Q2 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.17
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
17%
4 to 6 months
54%
7 to 9 months
26%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Cancer
- Multiple sclerosis
- Somatostatin
- Amyloidosis
- Hypophosphatemia
- Botulinum toxin
- Ulcerative colitis
- Fixed-dose combination
- Immune checkpoint
- Type 2 diabetes
- Migraine
- Breast cancer
- Adjuvant therapy
- Rheumatoid arthritis
- Toxicity
- Psoriasis
- Drug treatment
- Paroxysmal nocturnal hemoglobinuria
- Neuroendocrine tumors
- Breastfeeding
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Opinion on Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Safety assessment of cabozantinib in patients with renal cell carcinoma: retrospective pharmacovigilance study based on FAERS database
- 3 Apr 25
- Expert Opinion on Drug Safety
-
Full paper
Adverse events associated with aromatase inhibitors: An Analysis of Real-World Datasets and drug-gene interaction network
- 4 Mar 25
- Expert Opinion on Drug Safety
-
Full paper
Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
- 4 Mar 25
- Expert Opinion on Drug Safety
-
Full paper
Statin alternatives for the treatment of hypercholesterolemia - a safety evaluation
- 2 Jan 25
- Expert Opinion on Drug Safety
-
Full paper
Is metformin safe in pregnancy: a focus on offspring outcomes
- 2 Jan 25
- Expert Opinion on Drug Safety
-
Full paper
Adverse event profiles of drug-induced decreased libido: an assessment of the US food and drug administration adverse event reporting system
- 1 Dec 24
- Expert Opinion on Drug Safety
Scite analysis
Powered by scite_
2.8k articles received 44.7k citations see all
- 984 Supporting
- 41,448 Mentioning
- 165 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 16 Corrections
- 15 Errata
- 0 Expression of Concern
FAQs
How long has Expert Opinion on Drug Safety been actively publishing?
Expert Opinion on Drug Safety has been in operation since 2002 till date.
What is the publishing frequency of Expert Opinion on Drug Safety ?
Expert Opinion on Drug Safety published with a Bi-monthly frequency.
How many articles did Expert Opinion on Drug Safety publish last years ?
In 2023, Expert Opinion on Drug Safety published 179 articles.
What is the eISSN & pISSN for Expert Opinion on Drug Safety ?
For Expert Opinion on Drug Safety,eISSN is 1744-764X and pISSN is1474-0338.
What is Citescore for Expert Opinion on Drug Safety ?
Citescore for Expert Opinion on Drug Safety is 6.1.
What is H index for Expert Opinion on Drug Safety ?
H index for Expert Opinion on Drug Safety is 81.
What is SNIP score for Expert Opinion on Drug Safety ?
SNIP score for Expert Opinion on Drug Safety is 1.17.
What is the SJR for Expert Opinion on Drug Safety ?
SJR for Expert Opinion on Drug Safety is Q2.
Who is the publisher of Expert Opinion on Drug Safety ?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Drug Safety.